发明名称 Compositions for Inhibiting Gene Expression and Uses Thereof
摘要 The inventors have examined the means for providing more efficacious miRNA blocking compounds. The inventors have discovered new structural features that surprisingly improve the efficacy of miRNA blocking molecules. These features include the presence of multiple 3′ ends and a linker at the 5′ ends. Surprisingly, these features improve the efficacy of the gene expression blocking compounds in a manner that decreases the compound's biologic instability. Even more surprisingly, this effect has been found to be applicable to both DNA and RNA oligonucleotide-based compounds and to have application in traditional antisense and RNAi technology.
申请公布号 US2015044196(A1) 申请公布日期 2015.02.12
申请号 US201414495523 申请日期 2014.09.24
申请人 IDERA PHARMACEUTICALS, INC. 发明人 Agrawal Sudhir;Kandimalla Ekambar;Putta Mallikarjuna;Lan Tao;Nowak Ireneusz;LaMonica Nicola;Jiang Weiwen;Reardon Michael
分类号 C12N15/113;A61K45/06;A61K31/713 主分类号 C12N15/113
代理机构 代理人
主权项 1. A method for therapeutically treating a mammal having a disease or disorder mediated by a miRNA, the method comprising administering to the mammal a synthetic oligonucleotide-based compound comprising two single stranded oligonucleotides that are complementary to a miRNA sequence, wherein the oligonucleotides are linked at their 5′-ends such that the oligonucleotide-based compound has two accessible 3′-ends, and the oligonucleotides specifically hybridize to and inhibit the activity of the miRNA sequence.
地址 CAMBRIDGE MA US